We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




HIV Testing Critical to Reducing New Infections

By LabMedica International staff writers
Posted on 14 Jul 2011
A three-year initiative to test 2.8 million Americans for Human immunodeficiency virus (HIV) expanded access to testing in 25 United States areas most affected by the virus. More...


The program cost US$111 million and resulted in the diagnosis of 18,432 people who were unaware of their HIV status.

The effort, which was sponsored by the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), ran from October 2007 through September 2010 and helped state and local health departments support routine HIV testing in a variety of health care locations. A main focus was blacks, who are among the US populations most severely affected by HIV.

Although thirty years have passed since the CDC first reported AIDS-like disease, continuing to raise awareness about HIV and encouraging people to be tested remain important public health goals. Illinois Department of Public Health director Dr. Damon T. Arnold said, "On the 30th anniversary of the awareness of the disease, it remains critically important for people to get tested, know their HIV status, and be knowledgeable about their lives and health."

CDC currently funds 30 areas to reach populations at a higher risk for HIV, including African-Americans, gay, and bisexual men, Latinos, and injection drug users. The CDC launched its expanded testing to support 2006 recommendations for HIV testing to become a routine part of health care for adolescents and adults.

The three-year initiative's focus on testing African-Americans was successful, the centers reported. Hospital emergency rooms, STD clinics, and community-based organizations were three important types of venues in which testing occurred. Chicago was one of the 25 jurisdictions featured in the initiative.

Dr. Kevin Fenton, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, sexually transmitted diseases (STD) and tuberculosis (TB) prevention, was quoted as saying in a recent CDC news release. "These results demonstrate that the nation is making steady progress toward that vision. But more than half of US adults aged 18 to 64 still have never been tested for HIV, and our work is far from over."

Related Links:
US Centers for Disease Control and Prevention




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Gel Cards
DG Gel Cards
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.